K223666

Substantially Equivalent

Ablacath Mapping Catheter

Applicant: Ablacon, Inc.
Product code: MTD
Advisory panel: Cardiovascular
Date received: 2022-12-07
Decision date: 2023-03-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Denver, CO, US

Adverse events under product code MTD

product code MTD

Death: 22
Injury: 376
Malfunction: 986
Total: 1,384

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.